SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced its plans to participate in the 4th Systemic Sclerosis World Congress in Lisbon, Portugal, from February 18-20, 2016.
On Saturday, February 20, a session chaired by Dr. James Seibold and Professor Kazuhiko Takehara will focus on Emerging Therapies. Professor Guy Magalon from the Assistance Publique des Hôpitaux de Marseille (APHM) is scheduled to discuss two year data from the complete set of 12 patients treated in the SCLERADEC-I clinical study as part of a presentation entitled, “Treating Scleroderma of the Face and Hands with Fat and Stromal Vascular Fraction.”
